UBIAD1 and ocular melanoma: In the in vitro model, we found that the expression of UBIAD1 was decreased by 0.34 ± 0.06-fold of the control group after OGD/R, which was increased to 0.65 ± 0.06-fold of control with OM-MSC treatment, as demonstrated using western blot analysis (p < 0.01, Figures 5C,D).